Search
News
Universal FY2027 Q1 Earnings: Tobacco Timing Pressures Profit
Universal Corporation’s fiscal 2027 first-quarter revenue fell 12% to $523.8 million, while diluted EPS swung to a $0.20 loss from $0.34 a year earlier. Operating income dropped 93% to $2.3 million as lower tobacco volumes and prices, reduced carryover-crop sales, an unfavorable mix, and currency comparisons weighed on results. Ingredients revenue declined 3% and the segment posted a $0.7 million operating loss. Operating cash outflow improved to $117.1 million, while management expects tobacco shipments to be weighted toward the second half.
TradingKey
Wed, Aug 5
MIAX Q2 2026 Earnings: Options Growth Drives a 35% Net Revenue Increase
MIAX reported Q2 2026 net revenue of $141.1 million, up 35% year over year, as options volume and non-transaction fees supported growth. GAAP diluted EPS increased to $0.40 from $0.30, while adjusted EBITDA rose 57% to $76.8 million and margin reached 54%. A $30.0 million litigation settlement kept operating income growth to 2%, and adjusted EPS remained flat at $0.48 as the diluted share count increased. Options remained the largest segment, while equities and futures continued to report losses. The company also lowered its full-year adjusted operating expense guidance.
TradingKey
Wed, Aug 5
Dave Q2 2026 Earnings: Revenue Rises 30% as Adjusted EBITDA Margin Reaches 44%
Dave (Nasdaq: DAVE) reported Q2 2026 net operating revenue of $170.8 million, up 30% year over year, while GAAP diluted EPS fell to $0.49 from $0.62. Adjusted EBITDA rose 48% to $75.5 million, with margin expanding to 44%, as monthly transacting members and ExtraCash originations increased. GAAP net income was $6.7 million after $36.9 million of non-cash warrant and earnout remeasurement charges. Credit performance improved, and Dave raised its full-year revenue, adjusted EBITDA and adjusted diluted EPS guidance.
TradingKey
Wed, Aug 5
Solventum Q2 2026 Earnings: 9.5% Organic Growth Supports Higher Guidance
Solventum’s Q2 2026 earnings showed sales of $2.209 billion, up 2.2% reported and 9.5% organically, with GAAP diluted EPS of $0.53 and adjusted EPS of $2.55. Adjusted operating margin expanded 650 basis points to 28.4%, helped by an IEEPA tariff refund and ERP-related order timing, while GAAP operating margin fell amid legal, separation and restructuring costs. Quarterly free cash flow rose to $144 million, and Solventum raised its full-year organic growth, adjusted EPS and free cash flow guidance.
TradingKey
Wed, Aug 5
Miller Industries Q2 2026 Earnings: Revenue Growth Comes With Margin Pressure
Miller Industries (NYSE: MLR) reported Q2 2026 revenue of $240.0 million, up 12.1% year over year, while diluted EPS fell 13.7% to $0.63. Gross profit rose 3.9% to $35.9 million, but gross margin narrowed 120 basis points to 15.0% as operating costs grew faster than sales and Omars-related non-cash expenses reduced EPS by about $0.11. The company cut debt by $20 million from the end of Q1 and reaffirmed full-year revenue guidance of $850 million to $900 million.
TradingKey
Wed, Aug 5
F&G Q2 2026 earnings: Mark-to-market effects drive a GAAP loss
F&G Annuities & Life’s (NYSE: FG) second-quarter 2026 revenue rose about 4% to $1.421 billion, but diluted EPS swung to a $0.62 loss from $0.26 in earnings a year earlier. Net unfavorable mark-to-market effects of $144 million drove much of the GAAP loss, while adjusted net earnings fell to $85 million, or $0.65 per share. AUM before reinsurance reached a record $74.7 billion, up 8%, even as gross sales declined to $2.7 billion because F&G pulled back from lower-priority opportunistic volumes and maintained pricing discipline.
TradingKey
Wed, Aug 5
VIAVI Q4 FY2026 Earnings: Network Segment Drives 52.5% Revenue Growth
VIAVI Solutions’ fiscal Q4 2026 revenue rose 52.5% year over year to $443.1 million, led by 69.2% growth in Network and Service Enablement. GAAP diluted EPS increased to $0.13 from $0.04, while GAAP operating margin expanded 850 basis points to 13.8%. The company generated $66.7 million in operating cash flow and guided fiscal Q1 2027 revenue to $450 million–$460 million. Investors should monitor segment concentration, acquisition integration, financing costs, and the sizable gap between GAAP and non-GAAP results.
TradingKey
Wed, Aug 5
Heritage Q2 2026 Earnings: Lower Losses Lift Net Income 29%
Heritage Insurance Holdings’ Q2 2026 revenue rose 3.0% to $214.2 million, while diluted EPS increased 32.3% to $2.05 and net income reached $61.7 million. Profit growth was driven by lower losses, favorable prior-year reserve development, reduced weather losses and higher net premiums earned despite a 5.5% decline in gross premiums written. The net combined ratio improved to 64.9% from 72.9%, and operating cash flow was $166.5 million. Commercial residential pricing pressure remained a top-line constraint, while lower reinsurance costs supported premium retention and underwriting profitability.
TradingKey
Wed, Aug 5
SM Energy Q2 2026 Earnings: Higher Production Drives Record Operating Cash Flow
SM Energy’s Q2 2026 production revenue rose to $2.16 billion from $785 million, while GAAP diluted EPS increased to $4.46 from $1.76. Average production reached 439.7 MBoe/d, reflecting the first full quarter after the Civitas merger, and operating cash flow climbed to a record $1.10 billion. Adjusted free cash flow was $467 million. GAAP profit also benefited from a $262 million South Texas divestiture gain and favorable derivative fair-value changes. SM raised second-half production guidance, maintained full-year capital spending at $2.65–$2.85 billion, and reduced recurring G&A guidance.
TradingKey
Wed, Aug 5
Chord Energy Q2 2026 Earnings: Higher Oil Realizations Lift Cash Flow
Chord Energy’s Q2 2026 earnings showed total revenue rising about 84% year over year to $2.17 billion, while diluted EPS swung to $9.28 from a $6.77 loss. Adjusted EBITDA increased to $923.5 million and adjusted free cash flow reached $413.4 million, supported by oil production of 165.4 MBopd, stronger oil realizations and capital spending below guidance midpoint. The company maintained its 2026 oil-volume and capital-spending midpoints, raised its LOE midpoint and expects lower fourth-quarter oil volumes as fewer wells are turned in line.
TradingKey
Wed, Aug 5
Tronox Q2 2026 earnings: Revenue growth fails to prevent wider losses
Tronox’s Q2 2026 revenue rose 19% year over year to $868 million, but its GAAP diluted loss widened to $1.07 per share from $0.53. Adjusted EBITDA fell 22% to $73 million and margin contracted 430 basis points to 8.4%, as unfavorable currency movements, lower pricing and mix, and higher production and freight costs outweighed stronger TiO2 and zircon volumes. Free cash flow improved to $60 million. For Q3, Tronox expects adjusted EBITDA of $95 million to $115 million, higher pricing, seasonally lower volumes, and relatively neutral free cash flow.
TradingKey
Wed, Aug 5
Blue Owl Capital Corp. Q2 2026 Earnings: Dividend Coverage Holds as NAV Declines
Blue Owl Capital Corp. (OBDC) reported Q2 2026 total investment income of $401.3 million, down about 17.4% year over year, and diluted EPS of $0.13 versus $0.27. GAAP net investment income was $0.36 per share, while adjusted NII of $0.34 covered the $0.33 total dividend declared. However, realized and unrealized losses of $110.4 million contributed to NAV falling to $14.26 per share from $14.41 in the prior quarter. Lower borrowings reduced expenses, while repayments continued to exceed new investment funding.TradingKey
Wed, Aug 5
Albemarle Q2 2026 Earnings: Lithium Pricing Drives Margin Recovery
Albemarle’s Q2 2026 revenue rose 31% year over year to $1.74 billion, while diluted EPS improved to $3.52 from a $0.16 loss. Adjusted EBITDA increased 155% to $858 million as higher lithium pricing lifted Energy Storage and Specialties benefited from better pricing, volume, and productivity. The company generated $710 million in operating cash flow and $638 million in free cash flow, though timing and non-recurring working-capital benefits helped. Albemarle also raised its Specialties outlook and reduced expected 2026 capital spending to about $500 million.
TradingKey
Wed, Aug 5
Goodyear Q2 2026 earnings: Lower tire volume widens the adjusted loss
Goodyear’s Q2 2026 net sales fell 4.8% to $4.25 billion as tire unit volume declined 4.0%, while diluted GAAP EPS swung to a $0.71 loss from $0.87 of earnings a year earlier. Adjusted net loss widened to $177 million, and segment operating income dropped to $36 million as lower volume, tariffs, other costs and inflation outweighed pricing and Goodyear Forward benefits. Asia Pacific improved, but Americas replacement weakness remained the main drag. The planned Fayetteville closure targets approximately $270 million of annual operating-income improvement beginning in 2028.
TradingKey
Wed, Aug 5
Energy Fuels Q2 2026 earnings: Uranium sales lift revenue while deal costs widen the loss
Energy Fuels reported Q2 2026 revenue of $25.1 million, up from $4.2 million a year earlier, while diluted loss per share widened to $0.13 from $0.10. The company sold 310,000 pounds of U₃O₈ for $25.0 million, produced 865,000 pounds during the quarter and ended June with $996.0 million of working capital. Higher transaction costs tied to the planned VAC and ASM acquisitions and increased operating spending drove the larger net loss, even as uranium sales margins improved. Full-year uranium guidance remained unchanged.TradingKey
Wed, Aug 5
FNF Q2 2026 Earnings: Title Margin Expansion Offsets F&G Pressure
Fidelity National Financial (FNF) reported Q2 2026 revenue of $4.05 billion, up 11% from $3.64 billion, while diluted EPS increased to $1.08 from $1.02. Adjusted EPS rose to $1.39 from $1.16 as the Title segment delivered $448 million of adjusted pre-tax earnings and expanded its adjusted pre-tax margin to 17.8% from 15.5%. F&G’s adjusted contribution fell to $65 million from $89 million, reflecting FNF’s lower ownership stake, weaker alternative investment income and product-margin pressures, even as AUM before reinsurance grew 8% to $74.7 billion.TradingKey
Wed, Aug 5
Teknova Q2 2026 Earnings: Revenue Growth Drives Higher Guidance
Teknova’s fiscal Q2 2026 revenue rose 18% year over year to $12.2 million, while its net loss narrowed to $3.2 million, or $0.06 per diluted share. Gross margin expanded to 40.1%, and free cash outflow improved to $0.6 million from $2.3 million. Growth was broad across Lab Essentials and Clinical Solutions, although higher sales and marketing spending kept adjusted EBITDA negative. Teknova raised full-year 2026 revenue guidance to $45 million-$47 million and improved its free cash outflow outlook to less than $8 million.
TradingKey
Wed, Aug 5
Editas Medicine Q2 2026 earnings: Deferred revenue and restructuring narrow the loss
Editas Medicine’s Q2 2026 collaboration and other R&D revenue rose to $11.9 million from $3.6 million, while net loss narrowed to $18.2 million, or $0.15 per share, from $53.2 million, or $0.63 per share. The improvement was driven mainly by BMS-related deferred revenue and a $1.3 million restructuring benefit versus a $26.1 million charge, even as R&D expense increased to $20.2 million for EDIT-401. Cash reached $211.6 million after a $125.0 million gross equity offering, with runway expected into the second half of 2028.
TradingKey
Wed, Aug 5
BillionToOne Q2 2026 Earnings: Revenue Rises 64% as Gross Margin Expands
BillionToOne’s Q2 2026 revenue rose 64% year over year to $109.4 million, while diluted EPS improved to $0.15 from a $0.02 loss. Gross margin expanded five percentage points to 70%, supported by a 21% increase in overall average selling price and 35% growth in tests delivered. Prenatal revenue grew 55% to $94.2 million, and oncology revenue increased 176% to $13.7 million. The company generated $5.1 million of free cash flow and reiterated full-year 2026 revenue guidance of $450 million to $465 million.
TradingKey
Wed, Aug 5
Biodesix Q2 2026 earnings: Diagnostic testing growth narrows losses
Biodesix reported Q2 2026 revenue of $26.9 million, up 34% year over year, as Diagnostic Testing revenue increased 42% on 38% higher volumes and improved revenue per test. Gross margin rose 200 basis points to 82%, while the GAAP net loss narrowed to $7.3 million from $11.5 million and adjusted EBITDA loss improved to $3.2 million. The company maintained FY 2026 revenue guidance of $108 million to $114 million and an approximately 80% gross margin target, while Development Services revenue declined on project timing.
TradingKey
Wed, Aug 5
Featured Tools
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
Micron Stock Forecast: Can AI Memory Demand Push MU Above $1,000?
